NB1 cDNA polymorphisms
. | . | . | Polymorphisms . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | 34 . | 119 . | 141 . | 778 . | 1069 . | 1318 . | |||||
. | % . | . | C>G . | A>T . | G>A . | A>C . | G>A . | G>A . | |||||
Donor . | NB1+ . | mRNA . | Pro→Ala . | His→Leu . | Leu . | Ile→Leu . | Ala→Thr . | Gly→Arg . | |||||
1 | 83 | 2212 | c/G | a/T | g/A | a/C | g | g | |||||
2 | 81 | 743 | G | a | g | a | g | A | |||||
3 | 81 | 941 | c | a | g | a/C | g/A | g | |||||
4 | 76 | 1799 | G | a | A | a | g | A | |||||
5 | 75 | 6254 | c/G | a | g | a | g | g | |||||
6 | 74 | 397 | G | a | A | a | g | A | |||||
7 | 71 | 883 | G | T | A | a | g | A | |||||
8 | 68 | 7357 | c/G | a | g/A | a/C | g | g | |||||
9 | 63 | 3074 | c | a | g | a | g | g | |||||
10 | 61 | 6456 | c/G | a | g | a | g | g | |||||
11 | 61 | 3246 | c | a | g | a | g | g | |||||
12 | 37 | 33 | G | a | g | a/C | g/A | g | |||||
13 | 36 | 305 | G | a | g | C | A | g | |||||
14 | 32 | 1386 | G | T | A | C | A | g | |||||
15 | 26 | 272 | G | a | g | C | A | g | |||||
16 | 22 | 66 | G | a | g/A | C | g/A | g | |||||
17 | 20 | 204 | G | T | A | C | A | g | |||||
18 | 13 | 66 | G | a | g | C | g/A | g | |||||
19 | 10 | 463 | G | a | g | C | A | g | |||||
P | .001 | .02 | .778 | .840 | <.001 | <.001 | .206 |
. | . | . | Polymorphisms . | . | . | . | . | . | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | . | . | 34 . | 119 . | 141 . | 778 . | 1069 . | 1318 . | |||||
. | % . | . | C>G . | A>T . | G>A . | A>C . | G>A . | G>A . | |||||
Donor . | NB1+ . | mRNA . | Pro→Ala . | His→Leu . | Leu . | Ile→Leu . | Ala→Thr . | Gly→Arg . | |||||
1 | 83 | 2212 | c/G | a/T | g/A | a/C | g | g | |||||
2 | 81 | 743 | G | a | g | a | g | A | |||||
3 | 81 | 941 | c | a | g | a/C | g/A | g | |||||
4 | 76 | 1799 | G | a | A | a | g | A | |||||
5 | 75 | 6254 | c/G | a | g | a | g | g | |||||
6 | 74 | 397 | G | a | A | a | g | A | |||||
7 | 71 | 883 | G | T | A | a | g | A | |||||
8 | 68 | 7357 | c/G | a | g/A | a/C | g | g | |||||
9 | 63 | 3074 | c | a | g | a | g | g | |||||
10 | 61 | 6456 | c/G | a | g | a | g | g | |||||
11 | 61 | 3246 | c | a | g | a | g | g | |||||
12 | 37 | 33 | G | a | g | a/C | g/A | g | |||||
13 | 36 | 305 | G | a | g | C | A | g | |||||
14 | 32 | 1386 | G | T | A | C | A | g | |||||
15 | 26 | 272 | G | a | g | C | A | g | |||||
16 | 22 | 66 | G | a | g/A | C | g/A | g | |||||
17 | 20 | 204 | G | T | A | C | A | g | |||||
18 | 13 | 66 | G | a | g | C | g/A | g | |||||
19 | 10 | 463 | G | a | g | C | A | g | |||||
P | .001 | .02 | .778 | .840 | <.001 | <.001 | .206 |
NB1 cDNA polymorphisms and their appearance in donors with a large (> 60%, donors 1-11) and a small (< 40%, donors 12-19) NB1 GP+ subpopulation; mRNA: copies/5 × 106 cells; 2 letters: heterozygous expression; numbering according to Kissel et al.6 A significant association can be found between a low percentage of NB1 GP+ neutrophils and the polymorphisms 34C>G, 778A>C, and 1069G>A. The individuals with a small NB1 GP-bearing neutrophil subpopulation show also a significant lower NB1 GP mRNA formation